magnesium sulfate has been researched along with Hemorrhage, Subarachnoid in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.23) | 18.7374 |
1990's | 1 (1.23) | 18.2507 |
2000's | 37 (45.68) | 29.6817 |
2010's | 38 (46.91) | 24.3611 |
2020's | 4 (4.94) | 2.80 |
Authors | Studies |
---|---|
Kawauchi, S; Kondo, A; Kumagai, K; Mori, K; Nishida, S; Sato, S; Takeuchi, S; Toyooka, T; Wada, K | 1 |
Beez, A; Cattaneo, A; Ernestus, RI; Geske, C; Kunze, E; Lamllari, K; Messinger, J; Nickl, V; Pham, M; Semmler, F; Stetter, C; Weiland, J; Westermaier, T; Wipplinger, C; Wipplinger, TM | 1 |
An, Y; Sun, Y; Zhao, H | 1 |
Biais, M; Carrie, C; Cottenceau, V; Gariel, F; Petit, L; Poutier, B; Sauvage, N | 1 |
Amory, CF; Varelas, PN | 1 |
Feng, S; Gu, F; Hu, L; Song, Q; Zang, Y; Zhang, C; Zhao, S; Zhao, W | 1 |
Hammond, NE; Yarad, EA | 1 |
Assaad, N; Bradford, CM; Faulder, K; Finfer, S; Firth, R; Harrington, T; McCallister, R; Morgan, M; O'Connor, A; Steinfort, B; Yarad, E | 1 |
Fallah, A; Farrokhyar, F; Jichici, D; Macdonald, RL; Petropoulos, JA; Reddy, D | 1 |
Arimoto, H; Fujii, K; Mori, K; Nagatani, K; Osada, H; Otani, N; Takeuchi, S; Tomura, S; Wada, K | 1 |
Budohoski, KP; Bulters, DO; Helmy, A; Karri, SK; Kirkpatrick, PJ; Kirollos, RW; Ogilvy, CS; Trivedi, RA; Young, AM | 1 |
Esaki, T; Mori, K; Nakao, Y; Tokugawa, J; Watanabe, M; Yamamoto, T | 1 |
Al-Shahi Salman, R; Algra, A; Assaad, N; Boet, R; Boiten, J; Bradford, CM; Chan, MT; Conwit, R; Dirven, CM; Dorhout Mees, SM; Eckstein, M; Faulder, K; Finfer, S; Firth, R; Gin, T; Goldweber, R; Hamilton, S; Harrington, T; Kramer, I; Kuijsten, H; Lavados, PM; Liebeskind, DS; McCallister, R; Moreau, G; Morgan, M; Ng, SC; O'Connor, A; Poon, WS; Pratt, FD; Rinkel, GJ; Sanossian, N; Saver, JL; Starkman, S; Steinfort, B; Stratton, SJ; Sung, G; van den Bergh, WM; van Gijn, J; van Kooten, F; van Oostenbrugge, RJ; Vandertop, WP; Vermeulen, M; Wong, GK; Yarad, E; Zee, BC | 1 |
Malhi, J; Tichter, AM | 1 |
Dorhout Mees, SM | 1 |
Baljozović, BV; Djurović, BM; Dostanić, MM; Jovanović, VT; Milaković, BD; Milojević, TM; Nikolić, IM; Tasić, GM | 1 |
Aiko, Y; Hara, Y; Miyazaki, M; Mori, K; Nakao, Y; Yamamoto, T | 1 |
Rabinstein, AA; Zubkov, AY | 1 |
Georgiadis, AL; Kozak, OS; Memon, MZ; Qureshi, AI; Rodriguez, GJ; Shah, QA; Suri, MF; Taylor, RA; Tummala, RP; Vazquez, G | 1 |
Esaki, T; Hara, Y; Mori, K; Nakao, Y; Osada, H; Oyama, K; Yamamoto, T | 1 |
Chan, MT; Gin, T; Lam, CW; Poon, WS; Wong, GK | 1 |
Agner, C; Bernardini, GL; Boulos, AS; Feustel, P; Friedlich, D; Mesfin, F; Popp, AJ | 1 |
Shi, JX; Zhang, X; Zhao, XD; Zhou, YT; Zhuang, Z | 1 |
Ahuja, A; King, AD; Kwok, R; Poon, WS; Tang, K; Wong, GK; Yeung, D | 1 |
Bertens, D; Dorhout Mees, SM; Rinkel, GJ; van den Bergh, WM; van der Worp, HB | 1 |
Eriskat, J; Ernestus, RI; Kunze, E; Matthies, C; Pham, M; Roosen, K; Solymosi, L; Stetter, C; Tejon, JP; Vince, GH; Westermaier, T | 1 |
Chen, G; Fan, J; Liu, WG; Ma, L; Sheng, HS; Zhang, JM | 1 |
Boet, R; Chan, MT; Gin, T; Ng, SC; Poon, WS; Wong, GK; Zee, BC | 4 |
Taccone, FS | 1 |
Keller, E; Muroi, C | 1 |
Smith, SM | 1 |
Aiko, Y; Esaki, T; Hara, Y; Koike, N; Miyazaki, M; Mori, K; Nakao, Y; Sakamoto, S; Yamamoto, T | 2 |
Aiko, Y; Esaki, T; Hara, Y; Miyazaki, M; Mori, K; Nakao, Y; Yamamoto, T | 1 |
Chan, MT; Gin, T; Poon, WS; Wong, GK | 1 |
Horner, D | 1 |
Vergouwen, MD | 1 |
Abdo, WF; Hoedemaekers, CW; van der Hoeven, JG | 1 |
Suarez, JI | 1 |
Elhadi, SM; Hassan, T; Nassar, M; Radi, WK | 1 |
Keller, E; Mishima, K; Muroi, C; Seule, M | 1 |
Gromova, OA; Kalacheva, AG; Kuramshina, DB; Torshin, IIu | 1 |
Suarez, JI; Venkatasubba Rao, CP | 1 |
Al-Shahi Salman, R; Algra, A; Boiten, J; Dorhout Mees, SM; Kuijsten, HA; Lavados, PM; Rinkel, GJ; van den Bergh, WM; van Kooten, F; van Oostenbrugge, RJ; Vandertop, WP | 1 |
Poon, WS; Wong, GK | 4 |
Mori, K; Nagatani, K; Otani, N; Takeuchi, S; Wada, K | 1 |
Wong, GK | 1 |
Kamerling, NA; Nicolay, K; Rinkel, GJ; Tulleken, CA; van Asseldonk, JT; van den Bergh, WM; Zuur, JK | 1 |
Barile, M; Grandin, C; Hantson, P; Jativa, M; Mbia, JJ; Rooijakkers, H; van De Wyngaert, F | 1 |
Boet, R; Chan, MT; Poon, WS | 1 |
Aihara, Y; Curry, DJ; Jahromi, BS; Macdonald, RL; Yassari, R; Zhang, ZD | 1 |
Algra, A; Dirven, CM; Rinkel, GJ; van den Bergh, WM; van Gijn, J; van Kooten, F; Vermeulen, M | 1 |
Manno, EM | 1 |
Borel, CO; Brewer, RP; Macy, GE; McKee, JA; Reynolds, JD; Warner, DS | 1 |
Guterman, LR; Hopkins, LN; Kirmani, JF; Qureshi, AI; Yahia, AM | 1 |
Boet, R; Chan, MT; Poon, WS; Wong, GK | 2 |
Gupta, VK | 1 |
Araújo, JC; Chen, IB; Cordeiro, JG; de Morais, AL; Prevedello, DM; Saucedo, NS | 1 |
Boet, R; Chan, MT; Gin, T; Ng, SC; Poon, WS | 1 |
Boet, R; Chan, MT; Gin, T; Poon, WS; Wong, GK; Wong, HT | 1 |
Bradford, C; McElduff, A | 1 |
Boet, R; Chan, MT; Gin, T; Poon, WS; Wong, GK | 2 |
Poon, WW; Wong, GK | 1 |
Crago, E; Horowitz, MB; Kassam, A; Kerr, ME; Levy, EI; Stippler, M; Yonas, H | 1 |
Algra, A; Dorhout Mees, SM; Rinkel, GJ; van den Bergh, WM | 1 |
Chan, MT; Choi, KC; Poon, WS; Wong, GK | 1 |
Boet, R; Chan, MT; Gin, T; Lam, CW; Poon, WS; Wong, GK | 1 |
Fortunati, M; Keller, E; Muroi, C; Terzic, A; Yonekawa, Y | 1 |
Boet, R; Mee, E | 1 |
Borel, CO; Brewer, RP; Chilukuri, V; Lynch, J; Parra, A | 1 |
Burke, DG; Malik, GM; Marrocco, A; Mitsias, PD; Mlynarek, M; Nichols, V; Seyfried, D; Thomas, AJ; Veyna, RS; Zimmerman, C | 1 |
Sharbrough, FW; Sundt, TM; Szurszewski, J | 1 |
Hadani, M; Ram, Z; Sadeh, M; Sahar, A; Shacked, I | 1 |
16 review(s) available for magnesium sulfate and Hemorrhage, Subarachnoid
Article | Year |
---|---|
Intravenous magnesium therapy in adult patients with an aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
Topics: Adult; Humans; Infusions, Intravenous; Magnesium; Magnesium Sulfate; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2013 |
Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Topics: Calcium Channel Blockers; Humans; Intracranial Aneurysm; Magnesium Sulfate; Subarachnoid Hemorrhage | 2014 |
Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage: Individual Patient Data Meta-Analysis.
Topics: Aneurysm, Ruptured; Brain Ischemia; Calcium Channel Blockers; Early Medical Intervention; Humans; Intracranial Aneurysm; Magnesium Sulfate; Subarachnoid Hemorrhage; Time-to-Treatment; Treatment Outcome; Vasospasm, Intracranial | 2015 |
Medical management of cerebral vasospasm: present and future.
Topics: Endothelin Receptor Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnesium Sulfate; Nitric Oxide; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2009 |
A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate.
Topics: Anesthetics; Databases, Bibliographic; Humans; Magnesium Sulfate; Subarachnoid Hemorrhage | 2009 |
Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.
Topics: Brain Ischemia; Controlled Clinical Trials as Topic; Humans; Injections, Intravenous; Magnesium Sulfate; Neuroprotective Agents; Subarachnoid Hemorrhage; Treatment Outcome | 2010 |
Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: current status.
Topics: Calcium Channel Blockers; Case-Control Studies; Confidence Intervals; Female; Follow-Up Studies; Glasgow Outcome Scale; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Odds Ratio; Pilot Projects; Review Literature as Topic; Subarachnoid Hemorrhage | 2011 |
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3. Elevation of serum magnesium may improve clinical outcome after aneursymal subarachnoid haemorrhage.
Topics: Adult; Calcium Channel Blockers; Emergency Service, Hospital; Female; Humans; Intracranial Aneurysm; Magnesium; Magnesium Sulfate; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2011 |
Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis.
Topics: Cerebral Infarction; Humans; Injections, Intravenous; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic; Subarachnoid Hemorrhage; Treatment Outcome | 2011 |
Magnesium sulfate administration in subarachnoid hemorrhage.
Topics: Acute Disease; Anticonvulsants; Brain Ischemia; Critical Care; Humans; Magnesium Sulfate; Neuroprotective Agents; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2011 |
Novel treatments for vasospasm after subarachnoid hemorrhage.
Topics: Antihypertensive Agents; Clinical Trials, Phase III as Topic; Critical Care; Dioxanes; Female; Humans; Hypertension; Magnesium Sulfate; Male; Pyridines; Pyrimidines; Subarachnoid Hemorrhage; Sulfonamides; Tetrazoles; Vasospasm, Intracranial | 2012 |
[Molecular-biological basics of neuroprotection effects of magnesium].
Topics: Apoptosis; Blood Pressure; Brain Ischemia; Brain-Derived Neurotrophic Factor; Energy Metabolism; Humans; Magnesium; Magnesium Sulfate; Nerve Growth Factor; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Subarachnoid Hemorrhage | 2011 |
Magnesium sulphate for aneurysmal subarachnoid hemorrhage: why, how, and current controversy.
Topics: Brain Ischemia; Calcium Channel Blockers; Drug Administration Routes; Humans; Magnesium Sulfate; Subarachnoid Hemorrhage | 2013 |
Magnesium neuroprotection is limited in humans with acute brain injury.
Topics: Brain Injuries; Brain Ischemia; Eclampsia; Female; Homeostasis; Humans; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Subarachnoid Hemorrhage | 2005 |
Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea.
Topics: Calcium Channel Blockers; Humans; Magnesium Sulfate; Subarachnoid Hemorrhage; Time Factors | 2006 |
Physiological considerations important for the management of vasospasm.
Topics: Albuterol; Aminophylline; Autonomic Nervous System; Blood Pressure; Cerebrovascular Circulation; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Isoproterenol; Magnesium Sulfate; Muscle Contraction; Muscle, Smooth; Neurosurgery; Nucleotides, Cyclic; Receptors, Adrenergic; Reserpine; Subarachnoid Hemorrhage; Sympathomimetics; Time Factors | 1977 |
27 trial(s) available for magnesium sulfate and Hemorrhage, Subarachnoid
Article | Year |
---|---|
Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Topics: Adult; Brain Ischemia; Cerebral Infarction; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Nimodipine; Prospective Studies; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator Agents; Vasospasm, Intracranial; Young Adult | 2018 |
A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage.
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Cerebral Angiography; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Intracranial Aneurysm; Magnesium; Magnesium Sulfate; Male; Middle Aged; Prognosis; Subarachnoid Hemorrhage; Vasoconstriction; Vasospasm, Intracranial | 2013 |
Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.
Topics: Adult; Aged; Clinical Protocols; Humans; Hydrogen; Infusions, Intravenous; Infusions, Parenteral; Intracranial Aneurysm; Magnesium Sulfate; Middle Aged; Subarachnoid Hemorrhage | 2014 |
Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
Topics: Adult; Aged; Cerebral Angiography; Cisterna Magna; Female; Humans; Injections, Spinal; Magnesium Sulfate; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Pharmaceutical Solutions; Subarachnoid Hemorrhage; Therapeutic Irrigation; Tomography, X-Ray Computed; Ultrasonography, Doppler, Transcranial; Vasospasm, Intracranial | 2016 |
Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group.
Topics: Aneurysm, Ruptured; Anti-Arrhythmia Agents; Humans; Intracranial Aneurysm; Magnesium Sulfate; Subarachnoid Hemorrhage | 2008 |
The effect of hypermagnesemic treatment on cerebrospinal fluid magnesium level in patients with aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Cerebrospinal Fluid; Double-Blind Method; Female; Humans; Magnesium; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Subarachnoid Hemorrhage; Time Factors; Treatment Outcome | 2009 |
Effects of magnesium sulfate infusion on cerebral perfusion in patients after aneurysmal SAH.
Topics: Aneurysm; Calcium Channel Blockers; Cohort Studies; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Magnetic Resonance Imaging; Male; Middle Aged; Subarachnoid Hemorrhage; Tomography, X-Ray Computed | 2010 |
Magnesium and headache after aneurysmal subarachnoid haemorrhage.
Topics: Analgesics; Analgesics, Opioid; Codeine; Female; Headache; Humans; Injections, Intravenous; Logistic Models; Magnesium Sulfate; Male; Middle Aged; Pain Measurement; Pirinitramide; Stroke; Subarachnoid Hemorrhage; Tramadol | 2010 |
Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
Topics: Adult; Aged; Calcium Channel Blockers; Female; Hospitals, University; Humans; Hypoxia-Ischemia, Brain; Infusions, Intravenous; Intensive Care Units; Intracranial Aneurysm; Magnesium Sulfate; Male; Middle Aged; Prospective Studies; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2010 |
Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Subarachnoid Hemorrhage; Young Adult | 2010 |
Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: post hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial.
Topics: Adult; Aged; Female; Humans; Logistic Models; Magnesium; Magnesium Sulfate; Male; Middle Aged; Statistics, Nonparametric; Subarachnoid Hemorrhage; Treatment Outcome | 2010 |
Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: current status.
Topics: Calcium Channel Blockers; Case-Control Studies; Confidence Intervals; Female; Follow-Up Studies; Glasgow Outcome Scale; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Odds Ratio; Pilot Projects; Review Literature as Topic; Subarachnoid Hemorrhage | 2011 |
Health-related quality of life after aneurysmal subarachnoid hemorrhage: profile and clinical factors.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Glasgow Outcome Scale; Humans; Magnesium Sulfate; Male; Middle Aged; Quality of Life; Subarachnoid Hemorrhage; Surveys and Questionnaires; Young Adult | 2011 |
Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Nerve Growth Factors; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2012 |
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Pilot Projects; Subarachnoid Hemorrhage; Treatment Outcome; Young Adult | 2012 |
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
Topics: Brain Ischemia; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Subarachnoid Hemorrhage | 2005 |
The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Subarachnoid Hemorrhage; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasospasm, Intracranial | 2005 |
Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Calcium Channel Blockers; Craniotomy; Female; Humans; Length of Stay; Magnesium Sulfate; Male; Middle Aged; Morbidity; Subarachnoid Hemorrhage; Survival Rate; Treatment Outcome; Vasospasm, Intracranial | 2006 |
Magnesium sulfate for brain protection during temporary cerebral artery occlusion.
Topics: Brain; Brain Ischemia; Female; Humans; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Oxygen; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator Agents | 2005 |
Intravenous magnesium sulfate to improve outcome after aneurysmal subarachnoid hemorrhage: interim report from a pilot study.
Topics: Comorbidity; Double-Blind Method; Female; Hong Kong; Humans; Incidence; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Prognosis; Risk Assessment; Risk Factors; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator Agents; Vasospasm, Intracranial | 2005 |
Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study.
Topics: Acute Disease; Adult; Aged; Female; Glasgow Outcome Scale; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurosurgical Procedures; Prospective Studies; Risk Factors; Subarachnoid Hemorrhage; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasospasm, Intracranial | 2006 |
Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage.
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cohort Studies; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Severity of Illness Index; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2006 |
Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage.
Topics: Adult; Aged; Brain Ischemia; Female; Humans; Intracranial Aneurysm; Magnesium; Magnesium Sulfate; Male; Middle Aged; Odds Ratio; Prognosis; Regression Analysis; Subarachnoid Hemorrhage; Time Factors; Treatment Outcome | 2007 |
Magnsium and vasospasm.
Topics: Aneurysm, Ruptured; Female; Humans; Infusions, Intravenous; Intracranial Aneurysm; Magnesium Sulfate; Male; Middle Aged; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2007 |
Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
Topics: Adult; Aged; Brain Ischemia; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Prospective Studies; Single-Blind Method; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2008 |
Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Intracranial Aneurysm; Magnesium Sulfate; Male; Middle Aged; Middle Cerebral Artery; Placebos; Postoperative Complications; Pulmonary Artery; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vascular Resistance; Vasospasm, Intracranial | 2001 |
Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
Topics: Aneurysm, Ruptured; Blood Flow Velocity; Cerebral Angiography; Dose-Response Relationship, Drug; Female; Glasgow Outcome Scale; Humans; Infusions, Intravenous; Intracranial Aneurysm; Magnesium Sulfate; Male; Middle Aged; Prospective Studies; Single-Blind Method; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasospasm, Intracranial | 2002 |
39 other study(ies) available for magnesium sulfate and Hemorrhage, Subarachnoid
Article | Year |
---|---|
Local Application of Magnesium Sulfate Solution Suppressed Cortical Spreading Ischemia and Reduced Brain Damage in a Rat Subarachnoid Hemorrhage-Mimicking Model.
Topics: Analgesics; Animals; Brain Ischemia; Cerebrovascular Circulation; Cortical Spreading Depression; Disease Models, Animal; Magnesium Sulfate; Male; Pharmaceutical Solutions; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 2021 |
Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience.
Topics: Cerebral Infarction; Humans; Magnesium; Magnesium Sulfate; Neuroprotection; Retrospective Studies; Subarachnoid Hemorrhage | 2023 |
A letter to the editor: Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience.
Topics: Calcium Channel Blockers; Humans; Magnesium Sulfate; Neuroprotection; Retrospective Studies; Subarachnoid Hemorrhage | 2023 |
May levosimendan be safe and effective in refractory vasospasm despite adequate treatment with repeated angiography and milrinone infusion after subarachnoid haemorrhage?
Topics: Aneurysm, Ruptured; Cardiotonic Agents; Cerebral Angiography; Cerebrospinal Fluid Leak; Computed Tomography Angiography; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Embolization, Therapeutic; Humans; Infusions, Intravenous; Intracranial Aneurysm; Intracranial Pressure; Magnesium Sulfate; Male; Middle Aged; Milrinone; Nimodipine; Simendan; Subarachnoid Hemorrhage; Vasospasm, Intracranial; Ventricular Dysfunction, Left | 2019 |
Magnesium and Hydrogen in Subarachnoid Hemorrhage: Is Neuroprotection Finally a Reality?
Topics: Humans; Hydrogen; Magnesium; Magnesium Sulfate; Neuroprotection; Subarachnoid Hemorrhage | 2021 |
Pharmacologic Management of Subarachnoid Hemorrhage.
Topics: Adrenal Cortex Hormones; Animals; Anticoagulants; Apoptosis; Brain Ischemia; Calcium Channel Blockers; Clinical Trials as Topic; Dexamethasone; Dioxanes; Disease Models, Animal; Drugs, Chinese Herbal; Estrogens; Evidence-Based Medicine; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnesium Sulfate; Neuroprotective Agents; Nimodipine; Platelet Aggregation Inhibitors; Pregnatrienes; Progesterone; Pyridines; Pyrimidines; Receptor, Endothelin A; Subarachnoid Hemorrhage; Sulfonamides; Tetrazoles | 2015 |
Does Magnesium Therapy in Aneurysmal Subarachnoid Hemorrhage Affect Clinical Outcome?
Topics: Humans; Magnesium; Magnesium Sulfate; Subarachnoid Hemorrhage; Treatment Outcome | 2017 |
[Analysis of the therapeutic modalities when cerebral vasospasm occurs and the outcome of the treatment of patients with SAH].
Topics: Colloids; Humans; Magnesium Sulfate; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2008 |
Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage.
Topics: Animals; Cerebral Angiography; Cerebral Arteries; Cisterna Magna; Dogs; Injections; Magnesium Sulfate; Solutions; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2009 |
Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.
Topics: Adult; Aged; Analgesics; Angioplasty; Blood Pressure; Cerebral Arteries; Female; Humans; Infusions, Intra-Arterial; Magnesium Sulfate; Male; Middle Aged; Nicardipine; Retrospective Studies; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2009 |
Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Calcium Channel Blockers; Cerebral Angiography; Cerebral Arteries; Female; Humans; Injections, Intraventricular; Magnesium; Magnesium Sulfate; Male; Meningitis; Middle Aged; Postoperative Complications; Subarachnoid Hemorrhage; Subarachnoid Space; Treatment Outcome; Vasodilation; Vasodilator Agents; Vasospasm, Intracranial | 2009 |
Retrospective analysis of parenteral magnesium sulfate administration in decreased incidence of clinical and neuroradiological cerebral vasospasm: a single center experience.
Topics: Adult; Aged; Female; Humans; Infusions, Parenteral; Magnesium; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2009 |
Vasodilation and neuroprotection: the magnesium saga in subarachnoid hemorrhage.
Topics: Calcium Channel Blockers; Humans; Hypoxia-Ischemia, Brain; Intracranial Aneurysm; Magnesium Sulfate; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2010 |
Magnesium sulfate for subarachnoid hemorrhage: a piece of the mosaic.
Topics: Humans; Magnesium Sulfate; Subarachnoid Hemorrhage | 2010 |
Magnesium activation of the calcium-sensing receptor, a mechanism to reduce infarction and vasospasm in subarachnoid hemorrhage.
Topics: Calcium Channel Blockers; Humans; Hypoxia-Ischemia, Brain; Magnesium Sulfate; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2010 |
Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.
Topics: Animals; Basilar Artery; Blood Pressure; Calcium; Cerebral Angiography; Cerebral Arteries; Cisterna Magna; Dogs; Female; Injections; Magnesium; Magnesium Sulfate; Magnetic Resonance Imaging; Solutions; Subarachnoid Hemorrhage; Vasodilation; Vasospasm, Intracranial; Vertebral Artery | 2011 |
Temporal profile of the effects of intracisternal injection of magnesium sulfate solution on vasodilation of spastic cerebral arteries in the canine SAH model.
Topics: Angiography; Animals; Calcium Channel Blockers; Cerebral Arteries; Cisterna Magna; Disease Models, Animal; Dogs; Female; Magnesium; Magnesium Sulfate; Magnetic Resonance Imaging; Subarachnoid Hemorrhage; Time Factors; Vasodilation; Vasospasm, Intracranial | 2011 |
Magnesium sulfate for aneurysmal subarachnoid hemorrhage: the end of the road or more trials?
Topics: Humans; Magnesium Sulfate; Neuroprotective Agents; Subarachnoid Hemorrhage | 2011 |
Intravenous magnesium in subarachnoid hemorrhage.
Topics: Humans; Magnesium Sulfate; Neuroprotective Agents; Subarachnoid Hemorrhage | 2011 |
Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cisterna magna on cerebral vasospasm in the canine subarachnoid haemorrhage model.
Topics: Animals; Basilar Artery; Cerebral Arteries; Cisterna Magna; Disease Models, Animal; Dogs; Female; Injections, Spinal; Magnesium; Magnesium Sulfate; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial; Vertebral Artery | 2012 |
Magnesium and neuroprotection in subarachnoid haemorrhage.
Topics: Female; Humans; Magnesium Sulfate; Male; Neuroprotective Agents; Subarachnoid Hemorrhage | 2012 |
Clinical, transcranial Doppler ultrasound, radiological features and, prognostic significance of delayed cerebral ischemia.
Topics: Brain Ischemia; Cerebral Infarction; Female; Glasgow Coma Scale; Humans; Magnesium Sulfate; Male; Middle Cerebral Artery; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Regression Analysis; Subarachnoid Hemorrhage; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2013 |
Magnesium for aneurysmal subarachnoid haemorrhage.
Topics: Female; Humans; Magnesium Sulfate; Male; Neuroprotective Agents; Subarachnoid Hemorrhage | 2012 |
Magnesium for aneurysmal subarachnoid haemorrhage.
Topics: Female; Humans; Magnesium Sulfate; Male; Neuroprotective Agents; Subarachnoid Hemorrhage | 2012 |
Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage.
Topics: Animals; Brain Infarction; Brain Ischemia; Calcium Channel Blockers; Cortical Spreading Depression; Disease Models, Animal; Electrophysiology; Magnesium Sulfate; Magnetic Resonance Imaging; Male; Rats; Rats, Wistar; Subarachnoid Hemorrhage; Time Factors | 2002 |
Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage.
Topics: Belgium; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Magnetic Resonance Imaging; Middle Aged; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2003 |
Re: Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage.
Topics: Anticonvulsants; Humans; Magnesium Sulfate; Multicenter Studies as Topic; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2003 |
Magnesium and experimental vasospasm.
Topics: Animals; Dose-Response Relationship, Drug; Macaca fascicularis; Magnesium Sulfate; Neuroprotective Agents; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2004 |
Magnesium sulphate and cerebral vasospasm.
Topics: Humans; Magnesium Sulfate; Randomized Controlled Trials as Topic; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2005 |
Trial design in "magnesium sulphate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial".
Topics: Animals; Brain Ischemia; Follow-Up Studies; Humans; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic; Research Design; Subarachnoid Hemorrhage; Treatment Outcome | 2005 |
Magnesium for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: time for a paradigm shift?
Topics: Brain Ischemia; Humans; Intracranial Aneurysm; Magnesium Deficiency; Magnesium Sulfate; Neuroprotective Agents; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2005 |
An unusual cause of hypocalcaemia: magnesium induced inhibition of parathyroid hormone secretion in a patient with subarachnoid haemorrhage.
Topics: Anticonvulsants; Calcium; Female; Humans; Hypocalcemia; Magnesium; Magnesium Sulfate; Middle Aged; Parathyroid Hormone; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2006 |
Re: Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity (Prevedello DM et al. Surg Neurol 2006;65:S1:14-S1:21).
Topics: Cerebral Arteries; Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Magnesium Sulfate; Reproducibility of Results; Sample Size; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator Agents; Vasospasm, Intracranial | 2006 |
Correspondence to 'dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage'.
Topics: Animals; Anti-Arrhythmia Agents; Humans; Infusions, Intravenous; Magnesium Sulfate; Rats; Subarachnoid Hemorrhage | 2006 |
Interaction between magnesium sulfate and acetylsalicylic acid in the MASH trial.
Topics: Aspirin; Brain Ischemia; Central Nervous System Agents; Drug Interactions; Humans; Magnesium Sulfate; Randomized Controlled Trials as Topic; Research Design; Subarachnoid Hemorrhage | 2007 |
The effect of intravenous magnesium sulfate infusion on serum levels of sodium and potassium in patients with aneurysmal subarachnoid hemorrhage.
Topics: Aged; Aneurysm, Ruptured; Brain Ischemia; Female; Humans; Hypernatremia; Hypokalemia; Hyponatremia; Infusions, Intravenous; Intracranial Aneurysm; Magnesium; Magnesium Sulfate; Male; Middle Aged; Potassium; Retrospective Studies; Sodium; Subarachnoid Hemorrhage; Treatment Outcome | 2007 |
Re: Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial (Muroi et al. Surg Neurol 2008;69:33-39).
Topics: Anesthetics; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Humans; Hypotension; Magnesium Sulfate; Subarachnoid Hemorrhage | 2008 |
Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study.
Topics: Adult; Aged; Blood Flow Velocity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glasgow Outcome Scale; Humans; Infusions, Intravenous; Intracranial Aneurysm; Magnesium Sulfate; Male; Middle Aged; Pilot Projects; Postoperative Complications; Subarachnoid Hemorrhage; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasospasm, Intracranial | 2000 |
Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats.
Topics: Animals; Hemodynamics; Infusions, Intravenous; Ischemic Attack, Transient; Magnesium; Magnesium Sulfate; Male; Photography; Rats; Rats, Inbred Strains; Subarachnoid Hemorrhage | 1991 |